Verition Fund Management LLC Cardiol Therapeutics Inc. Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.67 - $2.97 $18,552 - $32,993
11,109 New
11,109 $22,000
Q1 2022

May 13, 2022
SELL
$1.25 - $2.31 $572,165 - $1.06 Million
-457,732 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$1.83 - $4.86 $837,649 - $2.22 Million
457,732 New
457,732 $847,000

Others Institutions Holding CRDL

# of Institutions
45
Shares Held
5.07M
Call Options Held
5.2K
Put Options Held
9.5K
View Full List

About Cardiol Therapeutics Inc.

CRDL Quotes by TradingView
  • Ticker CRDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 61,942,500
  • Market Cap $98.5M
  • Description
  • Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...
More about CRDL
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email